Christine Kirk is a partner and a member of the Healthcare and FDA practice group. Prior to joining the firm, Christine was a counsel at a Washington, DC-based boutique life sciences law firm where she focused her practice on providing clients strategic advice in the biopharma space. She worked with a multidisciplinary team of legal, scientific, and communications colleagues to assist biopharma clients from early drug development through post-approval compliance, including REMS requirements. She also assisted clients with drafting and pre-submission review of new drug application (NDA) and supplemental NDA (sNDA) documents, agency meeting requests and responses, citizen petitions, etc.
This is a temporary biography. A complete biography will be available soon.
